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A B S T R A C T
Two new diterpenoid α-pyrones, named higginsianins A and B, were isolated from the mycelium of the microbial
fungus Colletotrichum higginsianum grown in liquid culture. In previous studies, we have shown that both com-
pounds reduce viability of diﬀerent types of cancer cells in culture. Here, we extend our previous observations
and explore, at a deeper level, the cellular eﬀects of higginsianins treatment. Higginisianins A and B reduce
viability of A431, HeLa and H1299 cancer cells. Both compounds increase the level of the cell cycle inhibitor
p21WAF and reduce the rate of cell proliferation. Cell cycle analyses reveal that higginsianins arrest cancer cells
in S-phase. Furthermore, cells incubated with higginsianins reveal discrete γ-H2AX positive nuclear foci in-
dicating the occurrence of DNA lesions. At longer incubation times, higginsianins induce massive cell detach-
ment and non-apoptotic cell death. Human primary keratinocytes and spontaneously immortalized Hacat cells, a
preneoplastic cell line model, are less sensitive to higginsianins eﬀects. These ﬁndings suggest that higginsianins
exhibit considerable cytotoxicity against a wide spectrum of malignant cells and may be considered as promising
anticancer agents.
1. Introduction
Nature is an attractive source of new therapeutic candidate com-
pounds as potential anti-cancer agents (Bhanot et al., 2011). Microbial
fungi produce a plethora of secondary metabolites belonging to all the
classes of natural compounds. Fungal metabolites are also well known
as phytotoxins with potential application in agriculture as bioherbicides
(Cimmino et al., 2015; Masi et al., 2019) or in medicine as anticancer
compounds (Evidente et al., 2014).
The genus Colletotrichum is considered one of the most dangerous in
agriculture including a large number of fungal plant pathogens re-
sponsible for severe diseases to many cultivated plants. It is also well
known for its ability to synthesize a wide array of secondary metabo-
lites having various biological properties that can be exploited for
biotechnological applications (Garcia-Pajon and Isidro, 2003).
During a screening carried out on several Colletotrichum species
aimed to ﬁnd out sources of novel natural metabolites and/or biological
activities, two fungi were selected for their interesting biological
properties, namely Colletotrichum gleosporioides and Colletotrichum hig-
ginsianum.
The culture ﬁltrates of C. gleosporioides showed a very interesting
phytotoxic activity against Ambrosia artemisiifolia L., the worldwide
spread plant responsible for severe human allergies. In fact, from C.
gleosporioides culture ﬁltrates three phytotoxic metabolites were iso-
lated and identiﬁed as colletochlorin A, orcinol and tyrosol with the
ﬁrst one that induced large necrosis when assayed by leaf-punture assay
on A. artemisifolia (Masi et al., 2018).
From the mycelium of C. higginsianum, instead, two new diterpenoid
α-pyrones, named higginsianins A (Higg A) and B (Higg B) (Fig. 1),
were ﬁrstly isolated. Diterpenoid α-pyrones have previously been re-
ported to have immunosuppressive properties (Lim et al., 2015).
However, recent studies indicated that Higgs A and B reduce cancer cell
viability (Cimmino et al., 2016) and prompted a deeper study to in-
vestigate the potential of these two diterpenoid α-pyrones against
cancer cells.
Tumors of any given cell type may show a wide range of diﬀerence
in structure and properties and are characterized by molecular and
functional heterogeneity. Here, we show molecular evidence that Higgs
A and B have cytotoxic activity against several types of human cancer
cell lines.
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2. Materials and methods
2.1. General
Optical rotations were measured in a CHCl3 solution on a Jasco P-
1010 digital polarimeter (Tokyo, Japan). 1H and 13C NMR spectra were
recorded at 400/100MHz in CDCl3 on Bruker spectrometers (Karlsruhe,
Germany). The same solvent was used as internal standard. LC/MS
analyses were performed using the LC/MS TOF system (AGILENT
6230B, HPLC 1260 Inﬁnity, Milan, Italy) Analytical and preparative
TLC were performed on silica gel (Merck, Kieselgel 60, F254, 0.25 and
0.5 mm, respectively, Darmstadt, Germany) or on reverse phase
(Whatman, RP-18 F254, 0.20mm, Maidstone, UK) plates; the spots were
visualized by exposure to UV light and/or iodine vapors and/or by
spraying ﬁrst with 10% H2SO4 in MeOH and then with 5% phospho-
molybdic acid in EtOH followed by heating at 110 °C for 10min.
Column chomatography was performed using silica gel (Merck,
Kieselgel 60, 0.063–0.200mm).
2.2. Production, puriﬁcation of higginsianins A and B
Higginsianins A and B were isolated by the fungus C. higginsianum
grown on M1D medium as previously reported (Cimmino et al., 2016),
The mycelium, recovered from the culture ﬁltrates, was extracted with
EtOAc and the corresponding organic extract fractionated by column
and TLC chromatography to obtain higginsianins A and B as crystals
and homogeneous solid as detailed previously (Cimmino et al., 2016).
Higginsianins A and B were dissolved in DMSO and used at the in-
dicated ﬁnal concentrations and times.
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Fig. 1. The structures of higginsianins A and B.
Fig. 2. Crystal violet assay (CVA), Hacat, HeLa, H1299 and A431 cells were treated with diﬀerent concentrations (0.25–40 uM) of Higg A (2A) or B (2B) for 24 h. As a
control, cells were treated with an equal amount of DMSO in the absence of higginsianins. Cells were washed, ﬁxed and stained with crystal violet. Upon solubi-
lization, the amount of dye taken up by the monolayer was read at 570 nm for quantitation. Values shown in the plot are mean ± SE of three independent
experiments. 2.C F-actin staining, cells were allowed to adhere onto coverslips for 24 h and then treated with 1 μM and 10 μM Higg A or B for 24 h, ﬁxed and subjected
to TRITC-conjugated phalloidin and DAPI staining to visualize actin cytoskeleton and nuclei. Representative images are shown. Images were taken with a Zeiss
confocal laser-scanning microscope Axio Observer (scale bar, 20 μm). A 40× objective was used and image analysis was performed using ImageJ. All the images
were taken with the same setting. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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2.3. Cell culture and reagents
Human Epidermal Keratinocytes NHEK-neo (# 0019290 Lonza
Group, Basel Switzerland) were grown in KGMTN Gold keratinocyte
Growth Medium BulletKitTM (# 00192060). Hacat, spontaneously
immortalized keratinocytes from adult skin were purchased from
Service Cell Line (CLS, Germany) and cultured as described (Amoresano
et al., 2010; Vivo et al., 2009). HeLa cervical cancer cells (CCL-2),
Fig. 3. Eﬀect of higginsianins on the rate of cell proliferation. Hacat, A431, HeLa and H1299 cells were plated in DMEM with serum. Twenty-four hours later, the
medium was changed and supplemented with 1, 10 or 40 μM higginsianins A or B in DMSO. The cells were counted on days 1, 2, and 3. Untreated cells (NT) or cells
treated with DMSO alone were used as control. Values shown in the plot are mean ± SD of triplicate determinations. Asterisks represent signiﬁcant results at
p= .05.
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H1299 (CRL-5803) human non-small cell lung carcinoma and A431
(ATCC-CRL1555) human epidermoid carcinoma cells were from
American Type Culture Collection (ATCC, Manassas, VA). According to
the p53 compendium database (http://p53.fr/tp53-database/the-tp53-
cell-line-compendium), Hacat cells contain mutant p53 (H179Y/
R282W), HeLa have p53 impaired function by viral infection, H1299
are p53 null while A431 contain only one p53 mutated allele (R273H).
All mentioned cell lines were cultured in Dulbecco's Modiﬁed Eagle's
Medium (DMEM, Sigma Chemical Co, St. Louis, MO, USA) supple-
mented with 10% fetal bovine serum (FBS, Hyclone Laboratories, Inc.
Logan, UT, USA) at 37 °C in humiﬁed atmosphere of 5% CO2. All cell
lines were routinely tested for mycoplasma contamination and were not
infected.
2.4. Crystal violet assay (CVA)
Hacat, HeLa, H1299 and A431 cells were plated (2× 105) on a
60mM culture dishes and treated with DMSO or increasing con-
centrations (0.25, 0.50, 1, 10 and 40 μM) of Higg A or Higg B for 24 h.
After treatments, the culture medium was removed and cells were
covered with 2ml of ﬁxing solution (10% methanol; 10% acetic acid in
distilled H2O). Cells were then stained with crystal violet solution (0.5%
w/v crystal violet, 25% methanol in distilled H2O) for 20min at room
temperature. The stain solution was removed and dishes were washed
with water and air dried. Dead cells detach from the surface of the
culture plate and are removed from viable cell population during
washing steps. Upon solubilization, the amount of dye taken up by the
cell monolayer was quantitated in a spectrophotometer by reading the
absorbance at 570 nm.
2.5. Cell growth proﬁle
Cells were seeded at 1×105 in 35mm dishes and treated with Higg
A or Higg B at 1, 10, 40 μM for 48 h. Cells were harvested by suspension
in 0.025% trypsin in 0.02% EDTA solution. Cell counts were performed
in triplicates using a Neubauer chamber by trypan blue dye exclusion.
Brieﬂy, 20 μl cell suspension was diluted 1:1 with 0.4% solution of
trypan blue in phosphate saline buﬀer pH 7.2. Cell counting was carried
out at 24 h intervals for 3 days.
2.6. MTT assay
Cells were seeded at 2× 104 in 24 well plate and treated with Higg
A or Higg B (1 and 10mM) for 24 h. MTT solution 1:10 (stock solution
5mg/ml) was added to each well and the absorbance was measured in
dual wavelength mode (570 nm and 630 nm). The percentage of cell
viability was calculated as follows: mean (A570-A630). Values shown in
the plot are mean ± SD of triplicate determinations. Asterisks
Fig. 4. Eﬀect of lower doses of higginsianins. A, B. Hacat, A431, HeLa and H1299 cells were plated in DMEM with serum. Twenty-four hours later, the seeding medium
was changed and supplemented with 0.25, 0.5 or 1 μM Higg A or B in DMSO. The cells were counted after 24 h of treatment. C. The eﬀect of Higginsianins A and B on
primary Keratinocytes, Hacat and A431 cells. The cells indicated above were seeded in DMEM and treated 24 h hours later with 1 μM HiggA and HiggB. Cell viability
was measured by MTT assays. Values shown in the plot are mean ± SD of triplicate determinations. Asterisks represent signiﬁcant results at p= .05.
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represent signiﬁcant results at p= .05.
2.7. Cell cycle analysis
Cells were seeded at 3× 105 in 35mm dishes and treated with Higg
A or Higg B (10 μM) for 24 h. Cells were then trypsinized and washed by
centrifugation (12,000 rpm, 4min, 4 °C) in Phosphate Buﬀered Saline
(PBS 1×). The cell pellet was resuspended in ethanol, incubated in ice
for 2 h and centrifuged at 12000 rpm, 5min, 4 °C. After a wash in PBS,
the cell pellet was incubated in PBS 1×, containing RNase 100 μg/ml
for 20min at RT. Propidium Iodide was then added at a concentration
of 50 μg/ml for 30min at RT. Cell cycle analysis was performed on the
BD Accury™ C6 ﬂow cytometer (BD Biosciences). Cell debris and ag-
gregates were excluded from the analysis.
2.8. Western blot analysis
Western blot was performed as previously reported (di Martino
et al., 2016; Vivo et al., 2015). Brieﬂy, 25–30 μg of whole cell extracts
were separated by SDS-PAGE, subjected to western blot and incubated
overnight at 4 °C with antibodies. Antibodies against p21WAF, PARP1
and GAPDH were from Cell Signaling Technologies 9542, Boston, MA,
USA. Each experiment was run in triplicate. Signal intensities of Wes-
tern blot bands were quantiﬁed by Quantity One analysis software
(Biorad Laboratories, UK) and analyzed by GraphPad Prism 8.0.2
software.
2.9. Immunoﬂuorescence
Cells were seeded in 35mm dish on micro cover glasses (BDH) and
treated with Higgs A and B at 1 and 10 μM. At 24 h after treatment cells
were washed with cold phosphate-buﬀered saline (PBS) and ﬁxed with
4% paraformaldeide (Sigma-Aldrich, Germany) for 15min at RT. Cells
were permeabilized with ice-cold 0.5% Triton X-100 for 5min and then
washed with PBS. Cells were then incubated with tetra-
methylrhodamine-conjugated phalloidin for 30min or phospho-histone
H2A.X (Ser139) antibody (from Cell Signaling Technologies 9542,
Boston, MA, USA), followed by DAPI (Sigma-Aldrich) for 3min and
washed with PBS/0.05% Tween. Coverslip were mounted with Ibidi
mounting medium (Ibidi GmbH, Martinsried, Germany). Images were
taken with a Zeiss confocal laser-scanning microscope Axio Observer
(scale bar, 20 μm). A 40× objective was used and image analysis was
performed using ImageJ. All the images were taken with the same
setting (Vivo et al., 2017).
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Fig. 5. Cell cycle analysis. Hacat, A431, HeLa and H1299 cells were treated with DMSO alone or 1 μM higginsianin A or B for 24 h. Cell cycle distribution was analyzed
by ﬂow cytometer. After treatment, cells were ﬁxed and stained with a PI solution at a concentration of 50 μg/ml for 30min at RT. Cell cycle analysis was performed
by BD Accury™ C6 ﬂow cytometer (BD Biosciences). Bars represent an average of 3 measurements. Error bars represent the means± SD. Asterisks represent
signiﬁcant results at p= .05.
Table 1
Cell cycle analysis.
DMSO Higg A Higg B
mean sd n mean sd n mean sd n
Hacat G1 57,01 0,78 3 55,66 8,26 3 58,02 2,08 3
S 19,0 5,52 3 18,78 5,96 3 15,54 0,27 3
G2/M 23,98 4,74 3 25,57 2,31 3 26,45 1,82 3
A431 G1 69,85 0,50 3 39,29 2,66 3 47,36 5,49 3
S 15,28 0,79 3 44,99 1,15 3 37,18 0,23 3
G2/M 16,65 1,03 3 19,64 3,91 3 19,09 5,65 3
Hela G1 50,79 3,67 3 35,64 10,93 3 42,89 2,76 3
S 20,53 1,40 3 36,48 8,36 3 28,53 11,56 3
G2/M 28,88 2,33 3 28,15 2,04 3 29,10 13,85 3
H1299 G1 57,95 6,03 3 38,78 0,58 3 50,79 5,11 3
S 15,54 1,36 3 27,10 4,64 3 23,62 2,85 3
G2/M 26,25 5,04 3 34,13 3,81 3 25,77 2,51 3
Flow cytometry data. Hacat, A431, HeLa and H1299 cells were treated with
DMSO alone or 1mM HiggA or B for 24 h. After treatment, cells were ﬁxed and
stained with propidium iodide as detailed in Materials and methods. The ana-
lysis was performed with a BD Accury™ C6 ﬂow cytometer (BD Biosciences).
Data shown in the plot are the means± S.E of triplicates. Mean and standard
deviation (sd) was calculated on biological triplicates (n) using GraphPad Prism
8 software. Signiﬁcant results are shown in Fig. 2.
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2.10. Statistical analysis
Statistical analyses were carried out using the GraphPad Prism 8
software. Data were represented as the mean ± standard deviation and
analyzed for statistical signiﬁcance using ordinary one-way or two-
ways analysis of variance (ANOVA) and multiple comparisons. For all
test, P < .5 was considered to indicate a statistically signiﬁcant dif-
ference.
2.11. Transfection
Trypsinized cells were transfected using 1 μg of CMV or p53 plasmid
DNA by electroporation with Neon Transfection System Invitrogen
(1005 Voltage, 35 Width, 2 pulses) and seeded in 24 well at conﬂuence
2,5×104 each well. After 24 h cells were treated with Higg A or Higg B
(1 μM) for 24 h. MTT solution 1:10 (stock solution 5mg/ml) was added
to each well and the absorbance was measured in dual wavelength
mode (570 nm and 630 nm). The percentage of cell viability was cal-
culated as follows: mean (A570-A630). Values shown in the plot are
mean ± SD of triplicate determinations. Asterisks represent signiﬁcant
results at p= .05.
3. Results
3.1. Higginsianins A and B isolation
Higginsianins A and B (Fig. 1) were isolated from the mycelium of
C. higginsianum and their identity and purity were ascertained by
comparison with the previously reported chromatographic (TLC in
diﬀerent conditions), physic (speciﬁc optical rotation) and spectro-
scopic (1H and 13C NMR and ESI MS) data (Cimmino et al., 2016).
Fig. 6. Eﬀect of higginsianins on the p21WAF protein level. Representative immunoblots showing the eﬀects of higginsianins on p21WAF expression in Hacat (A) and
A431 (B) cells. Cells were incubated for 48 h with the indicated concentrations (1–40 μM) of Higg A or Higg B. Proteins were separated on 15% SDS-polyacrylamide
gel (25 μg/lane) and transferred to PVDF membranes. The level of p21WAF protein was analyzed via Western blotting with mouse monoclonal antibodies. The blots
were then re-probed with anti-GAPDH antibody, to conﬁrm an equal amount of protein loading. The signals intensities, indicated by numbers, were quantitated by
ImageLab software and expressed as the rate between p21WAF and GAPDH (Fig. 6C, bar graphs). Asterisks represent signiﬁcant results at p < .001 (***).
Fig. 7. Eﬀect of Higg A and B on PARP1 protein level in Hacat (Fig. 7A) and A431 cells (Fig. 7B). Representative immunoblots showing the eﬀects of higginsianins on
the PARP1 protein level. Proteins were separated on 10% SDS-polyacrylamide gel (25 μg/lane) and transferred to PVDF membranes. Protein bands were revealed
with antibodies directed against full length (113 kDa) and cleaved PARP1 (89 kDa). The blots were then re-probed with anti-GAPDH antibody, to conﬁrm an equal
amount of protein loading. The signals intensity was quantitated by ImageLab software and expressed as the rate between PARP1 and GAPDH signals as indicated by
the numbers.
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3.2. Higginsianins A and B cytotoxicity in human cancer cell lines
A preliminary evaluation of in vitro cytotoxic activity of Higgs A and
B was performed by crystal violet dye-binding Assay (CVA) against
A431, HeLa and H1299 human cancer cell lines. Spontaneously im-
mortalized Hacat keratinocytes were used as a preneoplastic cell line
model. As shown in Fig. 2A and B, after 24 h of treatment with in-
creasing concentrations of higginsianins (from 0 to 40 μM), we noticed
a reduction of the number of adherent cells in the culture plates com-
pared to cells treated with DMSO alone. A431 cells were the most
sensitive with a 50% reduction at 0.25 μM Higg A (Fig. 2A). However,
at 1 μM both Higgs A and B were able to reduce the number of all tested
cancer cell lines (Fig. 2A and B).
Moreover, given that higginsianin-treated cells rounded up and
detached from the plate, we examined the F-actin cytoskeleton struc-
ture by ﬂuorescence microscopy using tetramethylrhodamine-con-
jugated phalloidin. Treatments of Hacat cells with 1 or 10 μM Higgs A
or B induced a ﬂattened morphology and formation of stress ﬁbers
(Fig. 2C, left panel, white arrows). However, cells remain close to each
other and adherent to the surface (Fig. 2C, left panel). A431 cells, in-
stead, dramatically lose their cell-cell contacts resulting in empty holes
clearly visible in the cell monolayer (Fig. 2C, right panel, white arrows).
To evaluate the dose and time-dependence cytotoxicity of higgin-
sianins, we estimated the proliferation rate of cells treated with dif-
ferent concentrations, between 0 and 40 μM of Higg A or Higg B and
incubation times (24, 48 and 72 h). After 24 h of incubation with Higg A
or Higg B at concentration equal or higher than 1 μM, all cell lines
underwent growth arrest (Fig. 3A–H).
At 48 h of incubation with 1, 10 or 40 μM Higg A or Higg B, A431
and H1299 cells get detached from the plate while Hacat cells were able
to resume the growth (Fig. 3A and B). A similar behavior was observed
in HeLa cells treated with 1 μM Higg A or Higg B (Fig. 3E and F).
Furthermore, we performed a cell count after 24 h of treatment with
Higgs A or Higg B at concentrations lower than 1 μM (0.25 and
0.50 μM). Interestingly, while the number of Hacat cells was unaﬀected
by Higg A and slightly reduced by Higg B (92% at 0.25 and 75% at
0.5 μM Higg B), the number of cancer-derived cells was signiﬁcantly
reduced by both higginsianins (Fig. 4A and B).
Finally, we tested the sensitivity of human primary keratinocytes to
higginsianins treatment by comparing them with HaCaT and A431
cells. We performed MTT viability assay after treatment with 1 and
10 μM Higg A or B for 24 h. As shown in Fig. 4C, unlike immortalized
and transformed cells, the primary keratinocytes were almost in-
sensitive to higginsianin treatments.
Because of the profound inhibition of cell proliferation caused by
higginsianins we wanted to analyze if alterations in the cell cycle oc-
curred. The eﬀect of higginsianins on cell cycle progression was ana-
lyzed by ﬂow cytometry after 24 h of treatment with 1 μM Higgs A or B
(Fig. 5 and Table 1). As shown in Fig. 5A and Table 1, the cell cycle
distribution of Hacat cells was not signiﬁcantly aﬀected by both hig-
ginsianins except for a slight increase in G2/M phase (about 2%).
Conversely, all cancer cell lines were dramatically arrested in S-phase
(Fig. 5B, C and D). Indeed, after 24 h of treatment, the percentage of
A431 cells in S phase raised from 19 to 45% with Higg A and to 37%
with Higg B (Fig. 5B). Similarly, the percentage of H1299 cells in S
phase raised from 16 to 27% and 24% with Higgs A and B, respectively
Fig. 8. Immunoﬂuorescence microscopy showing γ-H2AX foci formation (green) in nuclei of Hacat (Fig. 8A) or A431 cells (Fig. 8B) treated for 24 h with DMSO alone,
1 or 10 μMHiggs A or B. Nuclei were stained with DAPI (blue). Note the highest number of γ-H2AX foci induced in A431 cells compared to Hacat cells. Images from 3
ﬁelds per each experimental point were collected to obtain data for up to 150 cells. Quantitation of γ-H2AX foci ﬂuorescence was performed by Image J software and
shown as mean ± SD in graph bars of panels D (Hacat) and E (A431) cells. Asterisks represent signiﬁcant results at p= .05. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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(Fig. 5D) while in HeLa cells the S phase cells raised from 21% to 36
and 29% with 1 μM Higgs A and B, respectively (Fig. 5C). The S phase
cell cycle arrest was essentially at the expense of the G1 phase in all cell
lines tested while the G2 phase was almost unaﬀected as in HeLa cells
or slightly increased as in A431 and H1299 cells (Fig. 5).
3.3. HiggA and B induce p21WAF expression level
To explore at molecular level the mechanism of higginsianin-in-
duced cell growth arrest, we examined by western blot analysis the
expression of p21WAF protein in Hacat and A431 cells after the treat-
ment with increasing concentrations of Higg A or Higg B. p21WAF is
the cyclin-dependent CDK4 and CDK2 inhibitor that halt cell cycle
progression in G1/S phase (Sherr and Roberts, 1999). As shown in
Fig. 6 A and B we found a dose-dependent increase of p21WAF in both
cell lines with either higginsianins. Interestingly, A431 cells exhibited a
stronger induction of p21WAF compared to Hacat cells (Fig. 6C).
Next, we have monitored PARP1 speciﬁc cleavage to evaluate the
occurrence of apoptosis in higginsianins-treated Hacat and A431 cells.
During apoptosis, PARP1 proteolytic cleavage by caspase 3 results in
the accumulation of a C-terminal 89 kDa fragment containing the cat-
alytic domain (Soldani and Scovassi, 2002). The proteolysis of PARP1
renders the enzyme inactive and this further facilitates apoptotic cell
death. Thus, the presence of a 89 kDa PARP1 fragment is considered to
be a very reliable biomarker of apoptosis. Unlike p53-null H1299
(Slovackova et al., 2012), Hacat and A431 cells are known to be
apoptosis proﬁcient despite their p53 mutant status (Lee et al., 2005;
Gulli et al., 1996). We examined the expression of PARP1 in Hacat and
A431 after 24 h treatment with increasing doses, from 1 to 40 μM, of
Higg A or Higg B by pooling ﬂoating and adherent cells and performing
immunoblot analysis. As shown in Fig. 7A and B we didn't observe
accumulation of cleaved PARP1 (89 kDa) thus indicating that cells were
undergoing non-apoptotic cell death.
3.4. Detection of DNA damage by immunoﬂuorescence
Detection of nuclear γ-H2A.X foci indirectly provide evidence of the
occurrence of DNA double strand breaks (DSB) and/or DNA replication
stress (Mejia-Ramirez et al., 2015; Gagou et al., 2010). Upon induction
of a DNA double-strand break, the H2A.X histone becomes rapidly
phosphorylated at Serine 139 to form gamma-H2AX [γH2AX; (Rogakou
et al., 1998)]. This phosphorylation event is dynamic, complex, and
depends on interactions between MDC1, H2AX, and ATM and other
kinases to persist (Savic et al., 2009). This ampliﬁed response is easily
detected using antibodies to γ-H2AX, manifesting discrete nuclear foci.
Given that higginsianins induces S-phase arrest we monitored for-
mation of γ-H2AX foci by immunoﬂuorescence. Hacat and A431 cells
were treated with 1 and 10 μM Higg A and B for 24 h. As shown in
Fig. 8A and B, higginsianin treatment caused a remarkable increase of
nuclear γH2AX foci (Fig. 8C, white arrows). The level of γ-H2A.X-po-
sitive ﬂuorescence intensity was signiﬁcantly increased after treatment
with Higg A or B (Fig. 8D and E). Interestingly, at the lower con-
centration tested (1 μM) Higg B appeared to be considerably less toxic
in Hacat cells than in A431cancer cells (Fig. 8D and E). All together
these data provide strong evidence that higginsianins treatment causes
DNA lesions that are likely responsible for the observed S-phase cell
cycle arrest.
4. Discussion
Isoprenoids have proven to have important antitumor activity
(Barbero et al., 2018). Taxol and aphidicolin, among them, are pro-
duced by plants and fungi and appear to be the most representative
among the diterpenes with antitumor activity (Hao et al., 2013).
Higginsianins A and B are two novel diterpenoid α-pyrones recently
isolated from C. higginsianum. The structural diﬀerence between Higgs
A and B lies in the region far from the main α-pyrone chromophore
(Fig. 1) and their structure and relative and absolute conﬁguration were
previously determined (Cimmino et al., 2016). By performing MTT
assays, both higginsianins were found to possess promising anti-
proliferative eﬀects against six distinct cancer cell lines derived from
oligodendroglioma, glioblastoma, melanoma, lung and breast cancer
(Cimmino et al., 2016).
Here, we have extended previous investigation by evaluating the
cytotoxic activity of higginsianins in immortalized and transformed
epithelial cells. The panel of cell lines selected for this study included
Hacat, A431 and HeLa cells which have mutant or viral inactivated p53
and H1299 cells which have the homozygous deletion of the p53 locus
(Reiss et al., 1992). Our data indicate that both higginsianins can eﬃ-
ciently induce p53-independent non-apoptotic cell death and are highly
toxic to all cancer cell lines in a dose and time-dependent manner.
Although the precise molecular mechanism of action of higginsia-
nins has to be determined, the up-regulation of the CDK inhibitor
p21WAF is likely responsible for the cytostatic activity of both hig-
ginsianins and suggests that it may be the primary target of action of
both metabolites.
Interestingly, we have evidence that higginsianin-treated cancer
cells arrest in S-phase and are unable to progress through the S-phase.
S-phase marks a particularly vulnerable time for cells to cope with DNA
damage. DNA lesions act as physical impediments to the replicative
polymerases. The induction of γ-H2A.X foci in cells treated with hig-
ginsianins provided clear evidence of the occurrence of DNA lesions.
Induction of p21WAF is usually associated to the cell cycle control at
the G1/S checkpoint; however, upregulation of p21WAF and induction
of S-phase arrest it is not unprecedented and has been previously de-
scribed in mouse ﬁbroblasts treated with cisplatin, etoposide or myto-
micin (Knudsen et al., 2000), in human melanocytes treated with thy-
midine dinucleotides (Pedeux et al., 1998), in human Saos-2 cells
transduced with the p21WAF gene (Ogryzko et al., 1997) and in human
cancer cell lines treated with 2,3 DCPE (2,3-dichlorophenoxy) propyl-
amino-ethanol (Zhu et al., 2004).
Our data indicate that both compounds were highly cytotoxic in
cancer cells while they were much less eﬀective in Hacat immortalized
keratinocytes. Indeed, Hacat keratinocytes can escape from the hig-
ginsianins-induced cytotoxic eﬀect and resume growth after a lag or
adaptation period. Remarkably, human primary keratinocytes appear
to be totally insensitive to Higg A up to 10 μM and slightly aﬀected by
10 μM Higg B. We can reasonably hypothesize that cells that fail to
repair DNA damage are more sensitive to higginsianin eﬀects.
Accordingly, as assessed by MTT assay, the rescue of p53 wild type
function in H1299 cancer cells decreased their sensitivity to a sublethal
dose of Higg A or Higg B (Supplementary Fig. 1).
It is tempting to speculate that, unlike transformed cancer cells,
healthy cells can still activate a checkpoint recovery pathway to over-
come the higginsianin-induced cellular damage.
At present, however, we cannot exclude that higginsianins treat-
ment, at higher doses or longer incubation times, may cause additional
cellular damage at the membranes or cytoskeleton structure which are
ﬁnally responsible for cell detachment. Given the absence of caspase-3
speciﬁc proteolytic cleavage of PARP1, we can conclude that higgin-
sianins treated cells underwent non-apoptotic cell death. This cytotoxic
eﬀect contradicts earlier ﬁndings (8) that higginsianins induce cell
death only in apoptosis proﬁcient cells. On the basis of these results,
higginsianins can be considered as attractive leads in the future de-
velopment of novel potential anticancer agents.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.tiv.2019.104614.
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